AKI, spol s. r.o.
About AKI, spol s. r.o.
"Nestátní zdravotnické zařízení s ambulantním provozem pro alergologii, klinickou imunologii, internu, revmatologii, ORL a rehabilitaci. Zajišťujeme léčebně preventivní péči v oboru pro všechny věkové kategorie. Součástí zdravotnického zařízení je imunologická a biochemická laboratoř a specializovaná lékárna."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at AKI, spol s. r.o.
During the past decade, AKI, spol s. r.o. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
2005-03-01
2018-08-01
Completed
4,216
Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer
2005-02-01
2014-04-01
Completed
290
Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma
2005-08-09
2017-05-04
Completed
127
Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
2005-12-13
2018-03-11
Completed
79
Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma
2006-10-01
2012-01-01
Completed
48
Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model
2005-06-01
2011-04-01
Completed
62
Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
2007-05-01
2023-05-01
Active, not recruiting
64
Chemotherapy-Induced Changes to Cognition and DNA in Breast Cancer Survivors
2007-06-01
2022-04-18
Completed
200
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at AKI, spol s. r.o.
According to Clinical.Site data, the most researched conditions in "AKI, spol s. r.o." are
"Allergic Rhinitis" (1 trials), "Allergic Rhinoconjunctivitis" (1 trials) and "Birch Pollen Induced Rhinitis/Rhinoconjunctivitis" (1 trials). Many other conditions were trialed in "AKI, spol s. r.o." in a lesser frequency.
Clinical Trials Intervention Types at AKI, spol s. r.o.
Most popular intervention types in "AKI, spol s. r.o." are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "SUBLIVAC FIX Birch" (2 trials). Other intervention names were less common.
Clinical Trials Genders at AKI, spol s. r.o.
The vast majority of trials in "AKI, spol s. r.o." are
2 trials for "All" genders.
Clinical Trials Status at AKI, spol s. r.o.
Currently, there are NaN active trials in "AKI, spol s. r.o.".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in AKI, spol s. r.o.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in AKI, spol s. r.o., 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".